	US 12,133,873 B2
	Composition for preventing, alleviating, or treating obesity or fatty liver disease, comprising Leuconostoc citreum WIKIM0104
Hak-Jong Choi, Seo-gu (KR); and Seul-Ki Lim, Seo-gu (KR)
Assigned to KOREA FOOD RESEARCH INSTITUTE, Wanju-Gun (KR)
Appl. No. 17/433,427
Filed by KOREA FOOD RESEARCH INSTITUTE, Jeollabuk-Do (KR)
PCT Filed Feb. 27, 2020, PCT No. PCT/KR2020/002845 § 371(c)(1), (2) Date Aug. 24, 2021, PCT Pub. No. WO2020/175940, PCT Pub. Date Sep. 3, 2020.
Claims priority of application No. 10-2019-0024254 (KR), filed on Feb. 28, 2019.
Prior Publication US 2022/0047652 A1, Feb. 17, 2022
Int. Cl. A61K 35/744 (2015.01); A23L 29/00 (2016.01); A61P 1/16 (2006.01)

CPC A61K 35/744 (2013.01) [A23L 29/065 (2016.08); A61P 1/16 (2018.01)]

3 Claims

1. A method of preventing, improving or treating obesity or a fatty liver disease by administering a composition comprising Leuconostoc citreum WiKim0104 deposited under accession number KCCM12420P, or a culture, a lysate or an extract thereof as an active ingredient to a subject in need thereof.